S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

VOXR Vox Royalty Corporation

2.22

-0.031 (-1.38%)

May 31 2024 - Closed

Delayed by 15 minutes

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

nullnullnullnullnullnull

Vox Royalty (NASDAQ:VOXR)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Vox Royalty Charts.

Vox Royalty (NASDAQ:VOXR)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Vox Royalty Charts.

Vox Royalty Corporation News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 30 May 2024 (3 days ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 14 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 8 May 2024 (4 weeks ago) • Edgar (US Regulatory)

Hemlo Explorers Announces Sale of Hawkins Gold Royalty
Friday 22 December 2023 (5 months ago) • GlobeNewswire Inc.

Vox Announces Full Exercise of Over-Allotment Option in Underwritten Public Offering of Common Shares
Tuesday 11 July 2023 (11 months ago) • GlobeNewswire Inc.

VOX ANNOUNCES CLOSING OF US$7.26 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON SHARES
Friday 16 June 2023 (12 months ago) • PR Newswire (Canada)

VOX ANNOUNCES PRICING OF US$7.26 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON SHARES
Tuesday 13 June 2023 (12 months ago) • PR Newswire (Canada)

VOX ANNOUNCES MARKETED OFFERING OF COMMON SHARES
Monday 12 June 2023 (12 months ago) • PR Newswire (Canada)

More Vox Royalty Corporation News Articles

Fannie Mae (QB)

Kraig Biocraft Laborator... (QB)

Enzolytics (PK)

ERHC Energy (CE)

Trump Media and Technology

CTR Investments and Cons... (CE)

Elite Pharmaceuticals (QB)

Anavex Life Sciences

Rennova Health (PK)

Branded Legacy (PK)

Net Savings Link (PK)

Northwest Biotherapeutics (QB)

Lightwave Logic

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions